{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:07Z","timestamp":1792783327855,"version":"4.5.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["No. U23A20261"],"award-info":[{"award-number":["No. U23A20261"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanghai Key Technology R&D Program 'Synthetic Biology' Project","award":["25HC2830500"],"award-info":[{"award-number":["25HC2830500"]}]},{"name":"Shanghai Agriculture Applied Technology Development Program, China","award":["No. 2024-02-08-00-12-F00040"],"award-info":[{"award-number":["No. 2024-02-08-00-12-F00040"]}]},{"name":"the Shuguang Program of Shanghai Education Development Foundation","id":[{"id":"https:\/\/ror.org\/02kq92y46","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Education Commission","id":[{"id":"https:\/\/ror.org\/05tewj457","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanghai Engineering Research Center of Food Microbiology","award":["No.19DZ2281100"],"award-info":[{"award-number":["No.19DZ2281100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11236-y","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:03:18Z","timestamp":1791446598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Faecalibacterium prausnitzii: Mechanistic Insights and Therapeutic Potential in Host\u2013Microbe Crosstalk"],"prefix":"10.1007","author":[{"given":"Wenfei","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianzhong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"11236_CR1","doi-asserted-by":"publisher","first-page":"2107386","DOI":"10.1080\/19490976.2022.2107386","volume":"14","author":"M Basic","year":"2022","unstructured":"Basic M, Dardevet D, Abuja PM et al (2022) Approaches to discern if microbiome associations reflect causation in metabolic and immune disorders. Gut Microbes 14:2107386. https:\/\/doi.org\/10.1080\/19490976.2022.2107386","journal-title":"Gut Microbes"},{"key":"11236_CR2","doi-asserted-by":"publisher","unstructured":"Wang J, Zhu N, Su X et al (2023) Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells 12. https:\/\/doi.org\/10.3390\/cells12050793","DOI":"10.3390\/cells12050793"},{"key":"11236_CR3","doi-asserted-by":"publisher","first-page":"1089909","DOI":"10.3389\/fnut.2023.1089909","volume":"10","author":"X Huang","year":"2023","unstructured":"Huang X, Yang Y, Li X et al (2023) The gut microbiota: a new perspective for tertiary prevention of hepatobiliary and gallbladder diseases. Front Nutr 10:1089909. https:\/\/doi.org\/10.3389\/fnut.2023.1089909","journal-title":"Front Nutr"},{"key":"11236_CR4","doi-asserted-by":"publisher","unstructured":"Chung RH, Kang CY (2019) A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification. GigaScience 8. https:\/\/doi.org\/10.1093\/gigascience\/giz045","DOI":"10.1093\/gigascience\/giz045"},{"key":"11236_CR5","doi-asserted-by":"publisher","first-page":"2020067","DOI":"10.1080\/19490976.2021.2020067","volume":"14","author":"P Singh","year":"2022","unstructured":"Singh P, Alm EJ, Kelley JM et al (2022) Effect of antibiotic pretreatment on bacterial engraftment after fecal microbiota transplant (FMT) in IBS-D. Gut Microbes 14:2020067. https:\/\/doi.org\/10.1080\/19490976.2021.2020067","journal-title":"Gut Microbes"},{"key":"11236_CR6","doi-asserted-by":"publisher","unstructured":"SC Chang HH, Chiang CY, Liu et al (2022) Intestinal mucosal barrier improvement with prebiotics: histological evaluation of longish glucomannan hydrolysates-induced innate T lymphocyte activities in mice. Nutrients 14. https:\/\/doi.org\/10.3390\/nu14112220","DOI":"10.3390\/nu14112220"},{"key":"11236_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/microorganisms10020297","volume":"10","author":"W Hu","year":"2022","unstructured":"Hu W, Gao W, Liu Z et al (2022) Biodiversity and physiological characteristics of novel Faecalibacterium prausnitzii strains isolated from human feces. Microorganisms 10:127. https:\/\/doi.org\/10.3390\/microorganisms10020297","journal-title":"Microorganisms"},{"key":"11236_CR8","doi-asserted-by":"publisher","unstructured":"Mart\u00edn R, Rios-Covian D, Huillet E et al (2023) Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol Rev 47. https:\/\/doi.org\/10.1093\/femsre\/fuad039","DOI":"10.1093\/femsre\/fuad039"},{"key":"11236_CR9","doi-asserted-by":"publisher","unstructured":"Miquel S, Mart\u00edn R, Rossi O et al (2013) Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol 16. https:\/\/doi.org\/10.1016\/j.mib.2013.06.003","DOI":"10.1016\/j.mib.2013.06.003"},{"key":"11236_CR10","doi-asserted-by":"publisher","first-page":"G607","DOI":"10.1152\/ajpgi.00303.2023","volume":"326","author":"B Xu","year":"2024","unstructured":"Xu B, Fu Y, Yin N et al (2024) Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii served as key components of fecal microbiota transplantation to alleviate colitis. Am J Physiol Gastrointest Liver Physiol 326:G607\u2013G621. https:\/\/doi.org\/10.1152\/ajpgi.00303.2023","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11236_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154722","author":"S Touch","year":"2022","unstructured":"Touch S, Godefroy E, Rolhion N et al (2022) Human CD4+\/CD8\u03b1+ regulatory T cells induced by Faecalibacterium prausnitzii protect against intestinal inflammation. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.154722","journal-title":"JCI Insight"},{"key":"11236_CR12","doi-asserted-by":"publisher","first-page":"e2100433","DOI":"10.1002\/mnfr.202100433","volume":"65","author":"X Mao","year":"2021","unstructured":"Mao X, Ma J, C Jiao, et al (2021) Faecalibacterium prausnitzii attenuates DSS-induced colitis by inhibiting the colonization and pathogenicity of candida albicans. Mol Nutr Food Res 65:e2100433. https:\/\/doi.org\/10.1002\/mnfr.202100433","journal-title":"Mol Nutr Food Res"},{"key":"11236_CR13","doi-asserted-by":"publisher","first-page":"101429","DOI":"10.1016\/j.xcrm.2024.101429","volume":"5","author":"J Li","year":"2024","unstructured":"Li J, Chen Z, Wang Q et al (2024) Microbial and metabolic profiles unveil mutualistic microbe-microbe interaction in obesity-related colorectal cancer. Cell Rep Med 5:101429. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101429","journal-title":"Cell Rep Med"},{"key":"11236_CR14","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","volume":"8","author":"HED Silva","year":"2018","unstructured":"Silva HED, Teterina A, Comelli EM et al (2018) Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. Sci Rep 8:1466. https:\/\/doi.org\/10.1038\/s41598-018-19753-9","journal-title":"Sci Rep"},{"key":"11236_CR15","doi-asserted-by":"publisher","first-page":"e3001556","DOI":"10.1371\/journal.pbio.3001556","volume":"20","author":"BT Tierney","year":"2022","unstructured":"Tierney BT, Tan Y, Yang Z et al (2022) Systematically assessing microbiome-disease associations identifies drivers of inconsistency in metagenomic research. PLoS Biol 20:e3001556. https:\/\/doi.org\/10.1371\/journal.pbio.3001556","journal-title":"PLoS Biol"},{"key":"11236_CR16","doi-asserted-by":"publisher","first-page":"43640","DOI":"10.1038\/srep43640","volume":"7","author":"SM Jandhyala","year":"2017","unstructured":"Jandhyala SM, Madhulika A, Deepika G et al (2017) Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities. Sci Rep 7:43640. https:\/\/doi.org\/10.1038\/srep43640","journal-title":"Sci Rep"},{"key":"11236_CR17","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1053\/j.gastro.2025.12.030","volume":"170","author":"C Kong","year":"2026","unstructured":"Kong C, Jin Y, Guo F et al (2026) Revealing the antagonistic interactions of Faecalibacterium prausnitzii and Bacteroides fragilis in colorectal cancer. Gastroenterology 170:1501\u20131517. https:\/\/doi.org\/10.1053\/j.gastro.2025.12.030","journal-title":"Gastroenterology"},{"key":"11236_CR18","doi-asserted-by":"publisher","first-page":"26034","DOI":"10.1038\/s41598-025-11042-6","volume":"15","author":"Y Gou","year":"2025","unstructured":"Gou Y, Yao L, Yang W et al (2025) Development of a three-species gut microbiome diagnostic model for acute pancreatitis and its association with systemic inflammation: a prospective cross-sectional study. Sci Rep 15:26034. https:\/\/doi.org\/10.1038\/s41598-025-11042-6","journal-title":"Sci Rep"},{"key":"11236_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41522-025-00845-0","volume":"11","author":"W Qin","year":"2025","unstructured":"Qin W, Mei Q, Wang G et al (2025) Faecalibacterium prausnitzii alleviates experimental recurrent acute pancreatitis by producing oleic acid to regulate MAPK\/NF-\u03baB signaling and Th17\/Treg balance. npj Biofilms Microbiomes 11:221. https:\/\/doi.org\/10.1038\/s41522-025-00845-0","journal-title":"npj Biofilms Microbiomes"},{"key":"11236_CR20","doi-asserted-by":"publisher","unstructured":"Sakamoto M, Sakurai N, Tanno H et al (2022) Genome-based, phenotypic and chemotaxonomic classification of Faecalibacterium strains: proposal of three novel species Faecalibacterium duncaniae sp. nov., Faecalibacterium hattorii sp. nov. and Faecalibacterium gallinarum sp. nov. Int J Syst Evol Microbiol 72. https:\/\/doi.org\/10.1099\/ijsem.0.005379","DOI":"10.1099\/ijsem.0.005379"},{"key":"11236_CR21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","volume":"11","author":"M Lopez-Siles","year":"2017","unstructured":"Lopez-Siles M, Duncan SH, Garcia-Gil LJ et al (2017) Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J 11:841\u2013852. https:\/\/doi.org\/10.1038\/ismej.2016.176","journal-title":"ISME J"},{"key":"11236_CR22","doi-asserted-by":"publisher","first-page":"104344","DOI":"10.1016\/j.micpath.2020.104344","volume":"149","author":"HE Leylabadlo","year":"2020","unstructured":"Leylabadlo HE, Ghotaslou R, Feizabadi MM et al (2020) The critical role of Faecalibacterium prausnitzii in human health: an overview. Microb Pathog 149:104344. https:\/\/doi.org\/10.1016\/j.micpath.2020.104344","journal-title":"Microb Pathog"},{"key":"11236_CR23","first-page":"126","volume":"89","author":"C Prausnitz","year":"1922","unstructured":"Prausnitz C (1922) Der bacillus mucosus anaerobius. Zentralbl Bakteriol Parasitenk Infektionskr Hyg Abt Orig 89:126\u2013113","journal-title":"Zentralbl Bakteriol Parasitenk Infektionskr Hyg Abt Orig"},{"key":"11236_CR24","first-page":"597","volume-title":"Dictionnaire des bact\u00e9ries pathog\u00e8nes","author":"P Hauduroy","year":"1937","unstructured":"Hauduroy P, Urbain G, Guillot G, Magrou J (1937) Dictionnaire des bact\u00e9ries pathog\u00e8nes. Masson et Cie, Paris, p 597"},{"key":"11236_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1099\/00207713-24-2-225","volume":"24","author":"EP Cato","year":"1974","unstructured":"Cato EP, Salmon CW, Moore WEC (1974) Fusobacterium prausnitzii (Hauduroy mooreholdeman: emended description designation of neotype strain. Int J Syst Bacteriol 24:225\u2013229. https:\/\/doi.org\/10.1099\/00207713-24-2-225","journal-title":"Int J Syst Bacteriol"},{"key":"11236_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1099\/00207713-46-1-341","volume":"146","author":"RF Wang","year":"1996","unstructured":"Wang RF, Cao WW, Cerniglia CEJIJSB (1996) Phylogenetic analysis of Fusobacterium prausnitzii based upon the 16S rRNA gene sequence and PCR confirmation. Int J Syst Bacteriol 146:341\u2013343. https:\/\/doi.org\/10.1099\/00207713-46-1-341","journal-title":"Int J Syst Bacteriol"},{"key":"11236_CR27","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1099\/ijs.0.02241-0","volume":"52","author":"SH Duncan","year":"2002","unstructured":"Duncan SH, Hold GL, Harmsen HJM et al (2002) Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol 52:2141\u20132146 https:\/\/doi.org\/10.1099\/ijs.0.02241-0","journal-title":"Int J Syst Evol Microbiol"},{"key":"11236_CR28","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1038\/s41598-021-90786-3","volume":"11","author":"Y Zou","year":"2021","unstructured":"Zou Y, Lin X, Xue W et al (2021) Characterization and description of Faecalibacterium butyricigenerans sp. nov. and F. longum sp. nov., isolated from human faeces. Sci Rep 11:11340. https:\/\/doi.org\/10.1038\/s41598-021-90786-3","journal-title":"Sci Rep"},{"key":"11236_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1128\/AEM.06858-11","volume":"78","author":"M Lopez-Siles","year":"2012","unstructured":"Lopez-Siles M, Khan TM, Duncan SH et al (2012) Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol 78:420\u2013428. https:\/\/doi.org\/10.1128\/AEM.06858-11","journal-title":"Appl Environ Microbiol"},{"key":"11236_CR30","doi-asserted-by":"publisher","first-page":"e116465","DOI":"10.1371\/journal.pone.0116465","volume":"9","author":"C Foditsch","year":"2014","unstructured":"Foditsch C, Santos TM, Teixeira AG et al (2014) Isolation and characterization of Faecalibacterium prausnitzii from calves and piglets. PLoS ONE 9:e116465. https:\/\/doi.org\/10.1371\/journal.pone.0116465","journal-title":"PLoS ONE"},{"key":"11236_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12864-018-5313-6","volume":"19","author":"CB Fitzgerald","year":"2018","unstructured":"Fitzgerald CB, Shkoporov AN, Sutton TDS et al (2018) Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa. BMC Genomics 19:931. https:\/\/doi.org\/10.1186\/s12864-018-5313-6","journal-title":"BMC Genomics"},{"key":"11236_CR32","doi-asserted-by":"publisher","first-page":"1993582","DOI":"10.1080\/19490976.2021.1993582","volume":"13","author":"RR Fagundes","year":"2021","unstructured":"Fagundes RR, Bourgonje AR, Saeed A et al (2021) Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium. Gut Microbes 13:1993582. https:\/\/doi.org\/10.1080\/19490976.2021.1993582","journal-title":"Gut Microbes"},{"key":"11236_CR33","doi-asserted-by":"publisher","first-page":"7280675","DOI":"10.1155\/mi\/7280675","volume":"2025","author":"M-C Liu","year":"2025","unstructured":"Liu MC, Shu YA, Wang YC et al (2025) Faecalibacterium prausnitzii colonization attenuates gut inflammation and epithelial damage in a DSS-induced colitis mice model. Mediators Inflamm 2025:7280675. https:\/\/doi.org\/10.1155\/mi\/7280675","journal-title":"Mediators Inflamm"},{"key":"11236_CR34","doi-asserted-by":"publisher","first-page":"1220044","DOI":"10.3389\/fendo.2023.1220044","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Wang JH, Shin JH et al (2023) Pharmaceutical efficacy of novel human-origin Faecalibacterium prausnitzii strains on high-fat-diet-induced obesity and associated metabolic disorders in mice. Front Endocrinol (Lausanne) 14:1220044. https:\/\/doi.org\/10.3389\/fendo.2023.1220044","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11236_CR35","doi-asserted-by":"publisher","first-page":"128217","DOI":"10.1016\/j.micres.2025.128217","volume":"298","author":"Y Pan","year":"2025","unstructured":"Pan Y, Zhao X, Chen Q et al (2025) Faecalibacterium prausnitzii extracellular vesicles regulating macrophage differentiation via homologous recombination repair in colitis model. Microbiol Res 298:128217. https:\/\/doi.org\/10.1016\/j.micres.2025.128217","journal-title":"Microbiol Res"},{"key":"11236_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12934-023-02243-7","volume":"22","author":"L Ye","year":"2023","unstructured":"Ye L, Wang Y, Xiao F et al (2023) F. prausnitzii-derived extracellular vesicles attenuate experimental colitis by regulating intestinal homeostasis in mice. Microb Cell Fact 22:235. https:\/\/doi.org\/10.1186\/s12934-023-02243-7","journal-title":"Microb Cell Fact"},{"key":"11236_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/microorganisms13030675","volume":"13","author":"E M\u00fcnte","year":"2025","unstructured":"M\u00fcnte E, Viebahn G, Khurana A et al (2025) Faecalibacterium prausnitzii is associated with disease severity in MASLD but Its supplementation does not improve diet-induced steatohepatitis in mice. Microorganisms 13:675. https:\/\/doi.org\/10.3390\/microorganisms13030675","journal-title":"Microorganisms"},{"key":"11236_CR38","doi-asserted-by":"publisher","first-page":"116588","DOI":"10.1016\/j.foodres.2025.116588","volume":"213","author":"A Wang","year":"2025","unstructured":"Wang A, Teng Y, Jin T et al (2025) Inhibitory effects of the cell-free supernatants of Faecalibacterium prausnitzii on biofilm formation of Listeria monocytogenes. Food Res Int 213:116588. https:\/\/doi.org\/10.1016\/j.foodres.2025.116588","journal-title":"Food Res Int"},{"key":"11236_CR39","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3390\/microorganisms13071705","volume":"13","author":"H Onodera","year":"2025","unstructured":"Onodera H, Sato Y, Komatsu Y et al (2025) HMOs induce butyrate production of Faecalibacterium prausnitzii via cross-feeding by Bifidobacterium bifidum with different mechanisms for HMO types. Microorganisms 13:1705. https:\/\/doi.org\/10.3390\/microorganisms13071705","journal-title":"Microorganisms"},{"key":"11236_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-023-06378-w","volume":"620","author":"MT Khan","year":"2023","unstructured":"Khan MT, Dwibedi C, Sundh D et al (2023) Synergy and oxygen adaptation for development of next-generation probiotics. Nature 620:381\u2013385. https:\/\/doi.org\/10.1038\/s41586-023-06378-w","journal-title":"Nature"},{"key":"11236_CR41","doi-asserted-by":"publisher","first-page":"fnv176","DOI":"10.1093\/femsle\/fnv176","volume":"362","author":"D Rios-Covian","year":"2015","unstructured":"Rios-Covian D, Gueimonde M, Duncan SH et al (2015) Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett 362:fnv176. https:\/\/doi.org\/10.1093\/femsle\/fnv176","journal-title":"FEMS Microbiol Lett"},{"key":"11236_CR42","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/microorganisms8050788","volume":"8","author":"H Kim","year":"2020","unstructured":"Kim H, Jeong Y, Kang S et al (2020) Co-Culture with Bifidobacterium catenulatum improves the growth, gut colonization, and butyrate production of Faecalibacterium prausnitzii: in vitro and in vivo studies. Microorganisms 8:788. https:\/\/doi.org\/10.3390\/microorganisms8050788","journal-title":"Microorganisms"},{"key":"11236_CR43","doi-asserted-by":"publisher","first-page":"e0362820","DOI":"10.1128\/mBio.03628-20","volume":"12","author":"LJ Lindstad","year":"2021","unstructured":"Lindstad LJ, Lo G, Leivers S et al (2021) Human gut Faecalibacterium prausnitzii deploys a highly efficient conserved system to cross-feed on \u03b2-mannan-derived oligosaccharides. mBio 12:e0362820. https:\/\/doi.org\/10.1128\/mBio.03628-20","journal-title":"mBio"},{"key":"11236_CR44","doi-asserted-by":"publisher","first-page":"1301073","DOI":"10.3389\/fmicb.2024.1301073","volume":"15","author":"C Xu","year":"2024","unstructured":"Xu C, Jiang H, Feng LJ et al (2024) Christensenella minuta interacts with multiple gut bacteria. Front Microbiol 15:1301073. https:\/\/doi.org\/10.3389\/fmicb.2024.1301073","journal-title":"Front Microbiol"},{"key":"11236_CR45","doi-asserted-by":"publisher","first-page":"wraf027","DOI":"10.1093\/ismejo\/wraf027","volume":"19","author":"H Negishi","year":"2025","unstructured":"Negishi H, Ichikawa A, Takahashi S et al (2025) Targeted prebiotic application of gluconic acid-containing oligosaccharides promotes Faecalibacterium growth through microbial cross-feeding networks. ISME J 19:wraf027. https:\/\/doi.org\/10.1093\/ismejo\/wraf027","journal-title":"ISME J"},{"key":"11236_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12916-025-04260-2","volume":"23","author":"W Qin","year":"2025","unstructured":"Qin W, Yin N, Xu B et al (2025) Faecalibacterium prausnitzii enhances intestinal IgA response by host-microbe derived inecalcitol in colitis. BMC Med 23:425. https:\/\/doi.org\/10.1186\/s12916-025-04260-2","journal-title":"BMC Med"},{"key":"11236_CR47","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s10620-025-09176-8","volume":"70","author":"P Zhang","year":"2025","unstructured":"Zhang P, Xu S, Li N et al (2025) Faecalibacterium prausnitzii ameliorates dss-induced colitis via modulating bile acid metabolism and regulating FXR signaling. Dig Dis Sci 70:3323\u20133339. https:\/\/doi.org\/10.1007\/s10620-025-09176-8","journal-title":"Dig Dis Sci"},{"key":"11236_CR48","doi-asserted-by":"publisher","first-page":"19399","DOI":"10.1038\/srep19399","volume":"6","author":"S Miquel","year":"2016","unstructured":"Miquel S, Martin R, Lashermes A et al (2016) Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep 6:19399. https:\/\/doi.org\/10.1038\/srep19399","journal-title":"Sci Rep"},{"key":"11236_CR49","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/biomedicines10051128","volume":"10","author":"IJ Dikeocha","year":"2022","unstructured":"Dikeocha IJ, Al-Kabsi AM, Chiu HT et al (2022) Faecalibacterium prausnitzii ameliorates colorectal tumorigenesis and suppresses proliferation of HCT116 colorectal cancer cells. Biomedicines 10:1128. https:\/\/doi.org\/10.3390\/biomedicines10051128","journal-title":"Biomedicines"},{"key":"11236_CR50","doi-asserted-by":"publisher","first-page":"e008831","DOI":"10.1136\/jitc-2024-008831","volume":"12","author":"J Guo","year":"2024","unstructured":"Guo J, Meng F, Hu R et al (2024) Inhibition of the NF-\u03baB\/HIF-1\u03b1 signaling pathway in colorectal cancer by tyrosol: a gut microbiota-derived metabolite. J Immunother Cancer 12:e008831. https:\/\/doi.org\/10.1136\/jitc-2024-008831","journal-title":"J Immunother Cancer"},{"key":"11236_CR51","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/jpen.1053","volume":"42","author":"S Roychowdhury","year":"2018","unstructured":"Roychowdhury S, Cadnum J, Glueck B et al (2018) Faecalibacterium prausnitzii and a prebiotic protect intestinal health in a mouse model of antibiotic and clostridium difficile exposure. JPEN J Parenter Enter Nutr 42:1156\u20131167. https:\/\/doi.org\/10.1002\/jpen.1053","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"11236_CR52","doi-asserted-by":"publisher","first-page":"1123547","DOI":"10.3389\/fmicb.2023.1123547","volume":"14","author":"J-H Shin","year":"2023","unstructured":"Shin JH, Lee Y, Song EJ et al (2023) Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet. Front Microbiol 14:1123547. https:\/\/doi.org\/10.3389\/fmicb.2023.1123547","journal-title":"Front Microbiol"},{"key":"11236_CR53","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/nu14142945","volume":"14","author":"W Hu","year":"2022","unstructured":"Hu W, Gao W, Liu Z et al (2022) Specific strains of Faecalibacterium prausnitzii ameliorate nonalcoholic fatty liver disease in mice in association with gut microbiota regulation. Nutrients 14:2945. https:\/\/doi.org\/10.3390\/nu14142945","journal-title":"Nutrients"},{"key":"11236_CR54","doi-asserted-by":"publisher","first-page":"2402208","DOI":"10.1183\/13993003.02208-2024","volume":"66","author":"RFJ Kullberg","year":"2025","unstructured":"Kullberg RFJ, van Linge CCA, de Vos AF et al (2025) Butyrate-producing gut bacterium Faecalibacterium prausnitzii protects against bacterial pneumonia. Eur Respir J 66:2402208. https:\/\/doi.org\/10.1183\/13993003.02208-2024","journal-title":"Eur Respir J"},{"key":"11236_CR55","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1002\/jsfa.11207","volume":"101","author":"W Hu","year":"2021","unstructured":"Hu W, Lu W, Li L et al (2021) Both living and dead Faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short\u2010chain fatty acid production. J Sci Food Agric 101:5563\u20135573. https:\/\/doi.org\/10.1002\/jsfa.11207","journal-title":"J Sci Food Agric"},{"key":"11236_CR56","doi-asserted-by":"publisher","first-page":"2505119","DOI":"10.1080\/19490976.2025.2505119","volume":"17","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wei Y, Han X et al (2025) Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation. Gut Microbes 17:2505119. https:\/\/doi.org\/10.1080\/19490976.2025.2505119","journal-title":"Gut Microbes"},{"key":"11236_CR57","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.xcrm.2021.100398","volume":"2","author":"A Ueda","year":"2021","unstructured":"Ueda A, Shinkai S, Shiroma H et al (2021) Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer\u2019s-type dementia. Cell Rep Med 2:100398. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100398","journal-title":"Cell Rep Med"},{"key":"11236_CR58","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13075-023-03118-3","volume":"25","author":"J Moon","year":"2023","unstructured":"Moon J, Lee AR, Kim H et al (2023) Faecalibacterium prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis. Arthrit Res Ther 25:130. https:\/\/doi.org\/10.1186\/s13075-023-03118-3","journal-title":"Arthrit Res Ther"},{"key":"11236_CR59","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1161\/circresaha.122.320184","volume":"131","author":"H Li","year":"2022","unstructured":"Li H, Xu M, Xu X et al (2022) Faecalibacterium prausnitzii attenuates CKD via butyrate-renal GPR43 axis. Circul Res 131:e120\u2013e134. https:\/\/doi.org\/10.1161\/circresaha.122.320184","journal-title":"Circul Res"},{"key":"11236_CR60","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1128\/AEM.02006-15","volume":"81","author":"M Lopez-Siles","year":"2015","unstructured":"Lopez-Siles M, Martinez-Medina M, Abella C et al (2015) Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease. Appl Environ Microbiol 81:7582\u20137592. https:\/\/doi.org\/10.1128\/AEM.02006-15","journal-title":"Appl Environ Microbiol"},{"key":"11236_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/872725","volume":"2014","author":"Y Cao","year":"2014","unstructured":"Cao Y, Shen J, Ran ZH (2014) Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Gastroenterol Res Pract 2014:1\u20137. https:\/\/doi.org\/10.1155\/2014\/872725","journal-title":"Gastroenterol Res Pract"},{"key":"11236_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2010.02057.x","author":"W Jia","year":"2010","unstructured":"Jia W, Whitehead RN, Griffiths L et al (2010) Is the abundance of Faecalibacterium prausnitzii relevant to Crohn\u2019s disease? FEMS Microbiol Lett. https:\/\/doi.org\/10.1111\/j.1574-6968.2010.02057.x. 310:138\u2009\u2013\u200944","journal-title":"FEMS Microbiol Lett"},{"key":"11236_CR63","doi-asserted-by":"publisher","first-page":"2374954","DOI":"10.1080\/2162402X.2024.2374954","volume":"13","author":"M Bredon","year":"2024","unstructured":"Bredon M, Danne C, Pham HP et al (2024) Faecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors. Oncoimmunology 13:2374954. https:\/\/doi.org\/10.1080\/2162402X.2024.2374954","journal-title":"Oncoimmunology"},{"key":"11236_CR64","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3390\/jcm12072558","volume":"12","author":"SD Shaikh","year":"2023","unstructured":"Shaikh SD, Sun N, Canakis A et al (2023) Irritable bowel syndrome and the gut microbiome: a comprehensive review. J Clin Med 12:2558. https:\/\/doi.org\/10.3390\/jcm12072558","journal-title":"J Clin Med"},{"key":"11236_CR65","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3390\/microorganisms11102493","volume":"11","author":"JF Garcia-Mazcorro","year":"2023","unstructured":"Garcia-Mazcorro JF, Amieva-Balmori M, Triana-Romero A et al (2023) Fecal microbial composition and predicted functional profile in irritable bowel syndrome differ between subtypes and geographical locations. Microorganisms 11:2793. https:\/\/doi.org\/10.3390\/microorganisms11102493","journal-title":"Microorganisms"},{"key":"11236_CR66","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/cells","volume":"10","author":"B Ahluwalia","year":"2021","unstructured":"Ahluwalia B, Iribarren C, Magnusson MK et al (2021) A distinct faecal microbiota and metabolite profile linked to bowel habits in patients with irritable bowel syndrome. Cells 10:1459. https:\/\/doi.org\/10.3390\/cells","journal-title":"Cells"},{"key":"11236_CR67","doi-asserted-by":"publisher","first-page":"2262130","DOI":"10.1080\/19490976.2023.2262130","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ma W, Mehta R et al (2023) Diet and gut microbial associations in irritable bowel syndrome according to disease subtype. Gut Microbes 15:2262130. https:\/\/doi.org\/10.1080\/19490976.2023.2262130","journal-title":"Gut Microbes"},{"key":"11236_CR68","doi-asserted-by":"publisher","first-page":"603","DOI":"10.14309\/ajg.0000000000003042","volume":"120","author":"R Quan","year":"2025","unstructured":"Quan R, Decraecker L, Appeltans I et al (2025) Fecal proteolytic bacteria and staphylococcal superantigens are associated with abdominal pain severity in irritable bowel syndrome. Am J Gastroenterol 120:603\u2013613. https:\/\/doi.org\/10.14309\/ajg.0000000000003042","journal-title":"Am J Gastroenterol"},{"key":"11236_CR69","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"215","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H et al (2024) Colorectal cancer: Recent advances in management and treatment. World J Clin Oncol 215:1136\u20131156. https:\/\/doi.org\/10.5306\/wjco.v15.i9.1136","journal-title":"World J Clin Oncol"},{"key":"11236_CR70","doi-asserted-by":"publisher","first-page":"1260796","DOI":"10.3389\/fonc.2023.1260796","volume":"13","author":"T Zhang","year":"2023","unstructured":"Zhang T, Miao YC (2023) Prognostic evaluation of preoperative systemic immune inflammatory index in patients with colorectal cancer. Front Oncol 13:1260796. https:\/\/doi.org\/10.3389\/fonc.2023.1260796","journal-title":"Front Oncol"},{"key":"11236_CR71","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.21037\/jgo-22-116","volume":"13","author":"S Obuya","year":"2022","unstructured":"Obuya S, Elkholy A, Avuthu N et al (2022) A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients. J Gastrointest Oncol 13:2282\u20132292. https:\/\/doi.org\/10.21037\/jgo-22-116","journal-title":"J Gastrointest Oncol"},{"key":"11236_CR72","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41591-025-03693-9","volume":"31","author":"G Piccinno","year":"2025","unstructured":"Piccinno G, Thompson KN, Manghi P et al (2025) Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer. Nat Med 31:2416\u20132429. https:\/\/doi.org\/10.1038\/s41591-025-03693-9","journal-title":"Nat Med"},{"key":"11236_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.medj.2020.07.001","volume":"2","author":"J Zhang","year":"2021","unstructured":"Zhang J, Huang Y, Yoon J et al (2021) Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture. Med 2:74\u201398. https:\/\/doi.org\/10.1016\/j.medj.2020.07.001","journal-title":"Med"},{"key":"11236_CR74","doi-asserted-by":"publisher","first-page":"2223345","DOI":"10.1080\/19490976.2023.2223345","volume":"15","author":"AJ Gonzales-Luna","year":"2023","unstructured":"Gonzales-Luna AJ, Carlson TJ, Garey KW (2023) Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies. Gut Microbes 15:2223345. https:\/\/doi.org\/10.1080\/19490976.2023.2223345","journal-title":"Gut Microbes"},{"key":"11236_CR75","doi-asserted-by":"publisher","first-page":"572912","DOI":"10.3389\/fcimb.2020.572912","volume":"10","author":"J Ramirez","year":"2020","unstructured":"Ramirez J, Guarner F, Bustos Fernandez L et al (2020) Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol 10:572912. https:\/\/doi.org\/10.3389\/fcimb.2020.572912","journal-title":"Front Cell Infect Microbiol"},{"key":"11236_CR76","doi-asserted-by":"publisher","unstructured":"Blachier F, Bj\u00f6rkqvist O, Rangel I et al (2021) Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection. PLoS One 16. https:\/\/doi.org\/10.1371\/journal.pone.0249861","DOI":"10.1371\/journal.pone.0249861"},{"key":"11236_CR77","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/ismej.2017.24","volume":"11","author":"E Munukka","year":"2017","unstructured":"Munukka E, Rintala A, Toivonen R et al (2017) Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. ISME J 11:1667\u20131679. https:\/\/doi.org\/10.1038\/ismej.2017.24","journal-title":"ISME J"},{"issue":"4","key":"11236_CR78","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3892\/ijmm.2018.3800","volume":"42","author":"KJP Schwenger","year":"2018","unstructured":"Schwenger KJP, Chen L, Chelliah A et al (2018) Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota in adults with non\u2013alcoholic fatty liver disease. Int J Mol Med 42(4):2229\u20132237. https:\/\/doi.org\/10.3892\/ijmm.2018.3800","journal-title":"Int J Mol Med"},{"key":"11236_CR79","doi-asserted-by":"publisher","first-page":"e00454","DOI":"10.1128\/jb.00454-20","volume":"203","author":"A Zhou","year":"2021","unstructured":"Zhou A, Lei Y, Tang L et al (2021) Gut microbiota: the emerging link to lung homeostasis and disease. J Bacteriol 203:e00454\u2013e00420. https:\/\/doi.org\/10.1128\/jb.00454-20","journal-title":"J Bacteriol"},{"key":"11236_CR80","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh YK, Zuo T, Lui GC et al (2021) Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70:698\u2013706. https:\/\/doi.org\/10.1136\/gutjnl-2020-323020","journal-title":"Gut"},{"key":"11236_CR81","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12866-018-1257-x","volume":"18","author":"Q Wang","year":"2018","unstructured":"Wang Q, Li F, Liang B et al (2018) A metagenome-wide association study of gut microbiota in asthma in UK adults. BMC Microbiol 18:114. https:\/\/doi.org\/10.1186\/s12866-018-1257-x","journal-title":"BMC Microbiol"},{"key":"11236_CR82","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.aller.2018.12.009","volume":"47","author":"M Demirci","year":"2019","unstructured":"Demirci M, Tokman HB, Uysal HK et al (2019) Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma. Allergol Immunopathol (Madr) 47:365\u2013371. https:\/\/doi.org\/10.1016\/j.aller.2018.12.009","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"307","key":"11236_CR83","doi-asserted-by":"publisher","first-page":"307ra152","DOI":"10.1126\/scitranslmed.aab2271","volume":"7","author":"MC Arrieta","year":"2015","unstructured":"Arrieta MC, Stiemsma LT, Dimitriu PA et al (2015) Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7(307):307ra152. https:\/\/doi.org\/10.1126\/scitranslmed.aab2271","journal-title":"Sci Transl Med"},{"issue":"3","key":"11236_CR84","doi-asserted-by":"publisher","first-page":"e0342024","DOI":"10.1128\/mbio.03420-24","volume":"16","author":"AJ Verster","year":"2025","unstructured":"Verster AJ, Salerno P, Valls R et al (2025) Persistent delay in maturation of the developing gut microbiota in infants with cystic fibrosis. mBio 16(3):e0342024. https:\/\/doi.org\/10.1128\/mbio.03420-24","journal-title":"mBio"},{"key":"11236_CR85","doi-asserted-by":"publisher","first-page":"26740","DOI":"10.31083\/rcm26740","volume":"26","author":"W Mao","year":"2025","unstructured":"Mao W, Zhou X, Wu C et al (2025) The critical role of Faecalibacterium prausnitzii in cardiovascular diseases. Rev Cardiovasc Med 26:26740. https:\/\/doi.org\/10.31083\/rcm26740","journal-title":"Rev Cardiovasc Med"},{"key":"11236_CR86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12964-023-01464-y","volume":"22","author":"HT Yang","year":"2024","unstructured":"Yang HT, Jiang ZH, Yang Y et al (2024) Faecalibacterium prausnitzii as a potential antiatherosclerotic microbe. Cell Commun Signal 22:54. https:\/\/doi.org\/10.1186\/s12964-023-01464-y","journal-title":"Cell Commun Signal"},{"key":"11236_CR87","doi-asserted-by":"publisher","first-page":"1683587","DOI":"10.3389\/fmicb.2025.1683587","volume":"16","author":"J Fu","year":"2025","unstructured":"Fu J, Bu G, Aimaier S et al (2025) Sex-specific association between gut Faecalibacterium prausnitzii and hypertension in male individuals. Front Microbiol 16:1683587. https:\/\/doi.org\/10.3389\/fmicb.2025.1683587","journal-title":"Front Microbiol"},{"key":"11236_CR88","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1038\/s41598-020-63475-w","volume":"10","author":"L Calderon-Perez","year":"2020","unstructured":"Calderon-Perez L, Gosalbes MJ, Yuste S et al (2020) Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study. Sci Rep 10:6436. https:\/\/doi.org\/10.1038\/s41598-020-63475-w","journal-title":"Sci Rep"},{"key":"11236_CR89","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/nu16071054","volume":"16","author":"A Dziedzic","year":"2024","unstructured":"Dziedzic A, Maciak K, Blizniewska-Kowalska K et al (2024) The power of psychobiotics in depression: a modern approach through the microbiota-gut-brain axis: a literature review. Nutrients 16:1051. https:\/\/doi.org\/10.3390\/nu16071054","journal-title":"Nutrients"},{"key":"11236_CR90","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.psyneuen.2019.02.025","volume":"104","author":"Z Hao","year":"2019","unstructured":"Hao Z, Wang W, Guo R et al (2019) Faecalibacterium prausnitzii (ATCC 27766) has preventive and therapeutic effects on chronic unpredictable mild stress-induced depression-like and anxiety-like behavior in rats. Psychoneuroendocrinology 104:132\u2013142. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.02.025","journal-title":"Psychoneuroendocrinology"},{"key":"11236_CR91","doi-asserted-by":"publisher","first-page":"1331486","DOI":"10.3389\/fimmu.2024.1331486","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Hong Q, Zhang X et al (2024) Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy. Front Immunol 15:1331486. https:\/\/doi.org\/10.3389\/fimmu.2024.1331486","journal-title":"Front Immunol"},{"key":"11236_CR92","doi-asserted-by":"publisher","first-page":"1617459","DOI":"10.3389\/fimmu.2025.1617459","volume":"16","author":"X Xie","year":"2025","unstructured":"Xie X, Liu H, Wan K et al (2025) The gut microbiota in osteoporosis: dual roles and therapeutic prospects. Front Immunol 16:1617459. https:\/\/doi.org\/10.3389\/fimmu.2025.1617459","journal-title":"Front Immunol"},{"key":"11236_CR93","doi-asserted-by":"publisher","unstructured":"Li J, Kuhn KA (2025) Microbial threads in the tapestry of rheumatoid arthritis. J Clin Invest 135. https:\/\/doi.org\/10.1172\/JCI195374","DOI":"10.1172\/JCI195374"},{"key":"11236_CR94","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12859-021-04199-0","volume":"22","author":"J Chen","year":"2021","unstructured":"Chen J, Wang A, Wang Q (2021) Dysbiosis of the gut microbiome is a risk factor for osteoarthritis in older female adults: a case control study. BMC Bioinformatics 22:299\u2013299. https:\/\/doi.org\/10.1186\/s12859-021-04199-0","journal-title":"BMC Bioinformatics"},{"key":"11236_CR95","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.3390\/ijms19102938","volume":"19","author":"A Picchianti-Diamanti","year":"2018","unstructured":"Picchianti-Diamanti A, Panebianco C, Salemi S et al (2018) Analysis of gut microbiota in rheumatoid arthritis patients: disease-related dysbiosis and modifications induced by etanercept. Int J Mol Sci 19:2938. https:\/\/doi.org\/10.3390\/ijms19102938","journal-title":"Int J Mol Sci"},{"key":"11236_CR96","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1038\/s41598-024-57122-x","volume":"14","author":"J Dong","year":"2024","unstructured":"Dong J, Shu G, Yang J et al (2024) Mechanistic study on the alleviation of postmenopausal osteoporosis by Lactobacillus acidophilus through butyrate-mediated inhibition of osteoclast activity. Sci Rep 14:7042. https:\/\/doi.org\/10.1038\/s41598-024-57122-x","journal-title":"Sci Rep"},{"key":"11236_CR97","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41467-017-02490-4","volume":"9","author":"S Lucas","year":"2018","unstructured":"Lucas S, Omata Y, Hofmann J et al (2018) Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun 9:55. https:\/\/doi.org\/10.1038\/s41467-017-02490-4","journal-title":"Nat Commun"},{"key":"11236_CR98","doi-asserted-by":"publisher","unstructured":"Wallimann A, Magrath W, Pugliese B et al (2021) Butyrate inhibits osteoclast activity in vitro and regulates systemic inflammation and bone healing in a murine osteotomy model compared to antibiotic-treated mice. Mediators Inflamm. 2021:8817421. https:\/\/doi.org\/10.1155\/2021\/8817421","DOI":"10.1155\/2021\/8817421"},{"key":"11236_CR99","doi-asserted-by":"publisher","first-page":"1543510","DOI":"10.3389\/fcell.2025.1543510","volume":"13","author":"W Wang","year":"2025","unstructured":"Wang W, Liu X, Nan H et al (2025) Specific gut microbiota and serum metabolite changes in patients with osteoarthritis. Front Cell Dev Biol 13:1543510. https:\/\/doi.org\/10.3389\/fcell.2025.1543510","journal-title":"Front Cell Dev Biol"},{"key":"11236_CR100","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","volume":"32","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel P, Poesen R, Meijers B (2017) The gut-kidney axis. Pediatr Nephrol 32:2005\u20132014. https:\/\/doi.org\/10.1007\/s00467-016-3527-x","journal-title":"Pediatr Nephrol"},{"key":"11236_CR101","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/toxins10070298","volume":"10","author":"B Meijers","year":"2018","unstructured":"Meijers B, Farre R, Dejongh S et al (2018) Intestinal barrier function in chronic kidney disease. Toxins (Basel) 10:298. https:\/\/doi.org\/10.3390\/toxins10070298","journal-title":"Toxins (Basel)"},{"key":"11236_CR102","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/MNH.0b013e328358c8d5","volume":"21","author":"ND Vaziri","year":"2012","unstructured":"ND Vaziri (2012) CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens 21:587\u2013592. https:\/\/doi.org\/10.1097\/MNH.0b013e328358c8d5","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"11236_CR103","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","volume":"109","author":"S Jiang","year":"2016","unstructured":"Jiang S, Xie S, Lv D et al (2016) A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek 109:1389\u20131396. https:\/\/doi.org\/10.1007\/s10482-016-0737-y","journal-title":"Antonie Van Leeuwenhoek"},{"key":"11236_CR104","doi-asserted-by":"publisher","unstructured":"Liu J, Yan Q, Li S et al (2024) Integrative metagenomic and metabolomic analyses reveal the potential of gut microbiota to exacerbate acute pancreatitis. npj Biofilms Microbiomes 10. https:\/\/doi.org\/10.1038\/s41522-024-00499-4","DOI":"10.1038\/s41522-024-00499-4"},{"key":"11236_CR105","doi-asserted-by":"publisher","first-page":"2489768","DOI":"10.1080\/19490976.2025.2489768","volume":"17","author":"C Zhang","year":"2025","unstructured":"Zhang C, Chen S, Wang Z et al (2025) Exploring the mechanism of intestinal bacterial translocation after severe acute pancreatitis: the role of Toll-like receptor 5. Gut Microbes 17:2489768. https:\/\/doi.org\/10.1080\/19490976.2025.2489768","journal-title":"Gut Microbes"},{"key":"11236_CR106","doi-asserted-by":"publisher","first-page":"2112882","DOI":"10.1080\/19490976.2022.2112882","volume":"14","author":"QX Mei","year":"2022","unstructured":"Mei QX, Fu Y, Huang ZH et al (2022) Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency. Gut Microbes 14:2112882. https:\/\/doi.org\/10.1080\/19490976.2022.2112882","journal-title":"Gut Microbes"},{"key":"11236_CR107","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1038\/s41467-023-41950-y","volume":"14","author":"G Li","year":"2023","unstructured":"Li G, Liu L, Lu T et al (2023) Gut microbiota aggravates neutrophil extracellular traps-induced pancreatic injury in hypertriglyceridemic pancreatitis. Nat Commun 14:6179. https:\/\/doi.org\/10.1038\/s41467-023-41950-y","journal-title":"Nat Commun"},{"key":"11236_CR108","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izy182","volume":"24","author":"L Zhou","year":"2018","unstructured":"Zhou L, Zhang M, Wang Y et al (2018) Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm Bowel Dis 24:1926\u20131940. https:\/\/doi.org\/10.1093\/ibd\/izy182","journal-title":"Inflamm Bowel Dis"},{"key":"11236_CR109","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1111\/bph.14806","volume":"176","author":"X Pan","year":"2019","unstructured":"Pan X, Fang X, Wang F et al (2019) Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms. Br J Pharmacol 176:4446\u20134461. https:\/\/doi.org\/10.1111\/bph.14806","journal-title":"Br J Pharmacol"},{"key":"11236_CR110","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12967-021-02882-7","volume":"19","author":"W Zhou","year":"2021","unstructured":"Zhou W, Zhang D, Li Z et al (2021) The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing. J Transl Med 19:215. https:\/\/doi.org\/10.1186\/s12967-021-02882-7","journal-title":"J Transl Med"},{"key":"11236_CR111","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","volume":"163","author":"N Nagata","year":"2022","unstructured":"Nagata N, Nishijima S, Kojima Y et al (2022) Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. Gastroenterology 163:222\u2013238. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.054","journal-title":"Gastroenterology"},{"key":"11236_CR112","doi-asserted-by":"publisher","first-page":"1103836","DOI":"10.3389\/fmicb.2022.1103836","volume":"13","author":"V Singh","year":"2022","unstructured":"Singh V, Lee G, Son H et al (2022) Butyrate producers, The Sentinel of Gut: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front Microbiol 13:1103836. https:\/\/doi.org\/10.3389\/fmicb.2022.1103836","journal-title":"Front Microbiol"},{"key":"11236_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1826748","volume":"12","author":"M Lenoir","year":"2020","unstructured":"Lenoir M, Mart\u00edn R, Torres-Maravilla E et al (2020) Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3. Gut Microbes 12:1\u201316. https:\/\/doi.org\/10.1080\/19490976.2020.1826748","journal-title":"Gut Microbes"},{"key":"11236_CR114","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/intimm\/dxz022","volume":"31","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhou L, Wang Y et al (2019) Faecalibacterium prausnitzii produces butyrate to decrease c-Myc-related metabolism and Th17 differentiation by inhibiting histone deacetylase 3. Int Immunol 31:499\u2013514. https:\/\/doi.org\/10.1093\/intimm\/dxz022","journal-title":"Int Immunol"},{"key":"11236_CR115","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","volume":"13","author":"DR Donohoe","year":"2011","unstructured":"Donohoe DR, Garge N, Zhang X et al (2011) The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13:517\u2013526. https:\/\/doi.org\/10.1016\/j.cmet.2011.02.018","journal-title":"Cell Metab"},{"key":"11236_CR116","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v23.i1.60","volume":"23","author":"D Zhou","year":"2017","unstructured":"Zhou D, Pan Q, Xin FZ et al (2017) Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. World J Gastroenterol 23:60\u201375. https:\/\/doi.org\/10.3748\/wjg.v23.i1.60","journal-title":"World J Gastroenterol"},{"key":"11236_CR117","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12876-016-0500-x","volume":"16","author":"M Zhang","year":"2016","unstructured":"Zhang M, Zhou Q, Dorfman RG et al (2016) Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol 16:84. https:\/\/doi.org\/10.1186\/s12876-016-0500-x","journal-title":"BMC Gastroenterol"},{"key":"11236_CR118","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3389\/fimmu.2017.01429","volume":"8","author":"MMM Kaisar","year":"2017","unstructured":"Kaisar MMM, Pelgrom LR, van der Ham AJ et al (2017) Butyrate conditions human dendritic cells to prime type 1 regulatory t cells via both histone deacetylase inhibition and G protein-coupled receptor 109A signaling. Front Immunol 8:1429. https:\/\/doi.org\/10.3389\/fimmu.2017.01429","journal-title":"Front Immunol"},{"key":"11236_CR119","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","volume":"65","author":"E Qu\u00e9vrain","year":"2016","unstructured":"Qu\u00e9vrain E, Maubert MA, Michon C et al (2016) Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease. Gut 65:415\u2013425. https:\/\/doi.org\/10.1136\/gutjnl-2014-307649","journal-title":"Gut"},{"key":"11236_CR120","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fmicb.2017.00114","volume":"8","author":"NM Breyner","year":"2017","unstructured":"Breyner NM, Michon C, de Sousa CS et al (2017) Microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-\u03baB pathway. Front Microbiol 8:114. https:\/\/doi.org\/10.3389\/fmicb.2017.00114","journal-title":"Front Microbiol"},{"key":"11236_CR121","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12967-025-07493-0","volume":"24","author":"X Guo","year":"2025","unstructured":"Guo X, Chen W, Zhang Y et al (2025) Microbial anti-inflammatory molecule (MAM) secreted by Faecalibacterium prausnitzii ameliorates colitis through autophagy and gut microbiota modulation. J Transl Med 24:149. https:\/\/doi.org\/10.1186\/s12967-025-07493-0","journal-title":"J Transl Med"},{"key":"11236_CR122","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3390\/ijms23031705","volume":"23","author":"S Auger","year":"2022","unstructured":"Auger S, Kropp C, Borras-Nogues E et al (2022) Intraspecific diversity of microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii. Int J Mol Sci 23:1705. https:\/\/doi.org\/10.3390\/ijms23031705","journal-title":"Int J Mol Sci"},{"key":"11236_CR123","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40168-025-02078-x","volume":"13","author":"J Xing","year":"2025","unstructured":"Xing J, Niu T, Yu T et al (2025) Faecalibacterium prausnitzii-derived outer membrane vesicles reprogram gut microbiota metabolism to alleviate Porcine Epidemic Diarrhea Virus infection. Microbiome 13:90. https:\/\/doi.org\/10.1186\/s40168-025-02078-x","journal-title":"Microbiome"},{"key":"11236_CR124","doi-asserted-by":"publisher","first-page":"107277","DOI":"10.1016\/j.phrs.2024.107277","volume":"206","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li L, Chen S et al (2024) Faecalibacterium prausnitzii-derived extracellular vesicles alleviate chronic colitis-related intestinal fibrosis by macrophage metabolic reprogramming. Pharmacol Res 206:107277. https:\/\/doi.org\/10.1016\/j.phrs.2024.107277","journal-title":"Pharmacol Res"},{"issue":"2","key":"11236_CR125","doi-asserted-by":"publisher","first-page":"e00300","DOI":"10.1128\/mBio.00300-15","volume":"6","author":"S Miquel","year":"2015","unstructured":"Miquel S, Leclerc M, Martin R et al (2015) Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. mBio 6(2):e00300\u2013e00315. https:\/\/doi.org\/10.1128\/mBio.00300-15","journal-title":"mBio"},{"key":"11236_CR126","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fmicb.2018.00346","volume":"9","author":"R Mart\u00edn","year":"2018","unstructured":"Mart\u00edn R, Berm\u00fadez-Humar\u00e1n LG, Langella P (2018) Searching for the bacterial effector: the example of the multi-skilled commensal bacterium Faecalibacterium prausnitzii. Front Microbiol 9:346. https:\/\/doi.org\/10.3389\/fmicb.2018.00346","journal-title":"Front Microbiol"},{"key":"11236_CR127","doi-asserted-by":"publisher","first-page":"8906","DOI":"10.1021\/acs.jafc.3c00283","volume":"71","author":"X Li","year":"2023","unstructured":"Li X, Mo K, Tian G et al (2023) Shikimic acid regulates the NF-\u03baB\/MAPK signaling pathway and gut microbiota to ameliorate DSS-induced ulcerative colitis. J Agric Food Chem 71:8906\u20138914. https:\/\/doi.org\/10.1021\/acs.jafc.3c00283","journal-title":"J Agric Food Chem"},{"key":"11236_CR128","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s12602-024-10213-7","volume":"17","author":"B Seo","year":"2025","unstructured":"Seo B, Jeon K, Kim WK et al (2025) Strain-specific anti-inflammatory effects of Faecalibacterium prausnitzii strain KBL1027 in Koreans. Probiotics Antimicrob Proteins 17:1711\u20131724. https:\/\/doi.org\/10.1007\/s12602-024-10213-7","journal-title":"Probiotics Antimicrob Proteins"},{"key":"11236_CR129","doi-asserted-by":"publisher","first-page":"919701","DOI":"10.3389\/fcimb.2022.919701","volume":"12","author":"Z Bai","year":"2022","unstructured":"Bai Z, Zhang N, Jin Y et al (2022) Comprehensive analysis of 84 Faecalibacterium prausnitzii strains uncovers their genetic diversity, functional characteristics, and potential risks. Front Cell Infect Microbiol 12:919701\u2013919701. https:\/\/doi.org\/10.3389\/fcimb.2022.919701","journal-title":"Front Cell Infect Microbiol"},{"key":"11236_CR130","doi-asserted-by":"publisher","first-page":"e96097","DOI":"10.1371\/journal.pone.0096097","volume":"5","author":"MT Khan","year":"2014","unstructured":"Khan MT, van Dijl JM, Harmsen HJM (2014) Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. PLoS ONE 5:e96097. https:\/\/doi.org\/10.1371\/journal.pone.0096097","journal-title":"PLoS ONE"},{"key":"11236_CR131","doi-asserted-by":"publisher","first-page":"101608","DOI":"10.1016\/j.jddst.2020.101608","volume":"56","author":"A Raise","year":"2020","unstructured":"Raise A, Dupont S, Iaconelli C et al (2020) Comparison of two encapsulation processes to protect the commensal gut probiotic bacterium Faecalibacterium prausnitzii from the digestive tract. J Drug Deliv Sci Technol 56:101608. https:\/\/doi.org\/10.1016\/j.jddst.2020.101608","journal-title":"J Drug Deliv Sci Technol"},{"key":"11236_CR132","doi-asserted-by":"publisher","unstructured":"Qiu B, Jing H, Han S et al (2024) Enhanced gut microbiota delivery of a model probiotic (Faecalibacterium prausnitzii): layer-by-layer encapsulation using riboflavin-conjugated sodium alginate and glycol chitosan. Food Hydrocoll 154. https:\/\/doi.org\/10.1016\/j.foodhyd.2024.110055","DOI":"10.1016\/j.foodhyd.2024.110055"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11236-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11236-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11236-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:03:22Z","timestamp":1791446602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11236-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":132,"alternative-id":["11236"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11236-y","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"14 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}